Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037752 · ClinicalTrials.gov registry record · NA
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT00037752: Completed NA study, sponsored by University of Tennessee.
NCT00037752 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 436 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00037752, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
Interventions
- DRUG Sibutramine
- BEHAVIORAL Behavioral Smoking Cessation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00037752 record still lists
NCT00037752 is an interventional study that assigns participants to a tested intervention. The registered 436 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Sibutramine is the first listed.
NCT00037752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00037752 about?
NCT00037752 is a clinical study titled "Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates". The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
What is the current status of trial NCT00037752?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2002-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00037752?
The interventions under investigation include: Sibutramine (DRUG), Behavioral Smoking Cessation Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00037752?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00037752's enrollment target sits among peer trials
436 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- NCT07318493 · 436 participants · NA
Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia